We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $147M invested in VanEck Biotech ETF in 2022 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 23 increasing their positions, 35 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

321% more call options, than puts

Call options by funds: $1.02M | Put options by funds: $243K

0.2% more ownership

Funds ownership: 30.44% → 30.64% (+0.2%)

9% less funds holding

Funds holding: 126 → 115 (-11)

14% less capital invested

Capital invested by funds: $171M → $147M (-$23.5M)

34% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 35

38% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 21

Holders
115
Holders Change
-11
Holders Change %
-8.73%
% of All Funds
1.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
23
Reduced
35
Closed
21
Calls
$1.02M
Puts
$243K
Net Calls
+$781K
Net Calls Change
+$2.1M

Top Buyers

Rank Fund Capital Flow
1
TIA
Traphagen Investment Advisors
New Jersey
+$8.97M
2
CIG
Consolidated Investment Group
Colorado
+$2.92M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.47M
4
CCA
Conservest Capital Advisors
Pennsylvania
+$1.85M
5
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$1.69M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$9.88M
2
Morgan Stanley
Morgan Stanley
New York
-$2.7M
3
Chevy Chase Trust
Chevy Chase Trust
Maryland
-$2.61M
4
FFN
Focus Financial Network
Minnesota
-$2.15M
5
CIBC Private Wealth Group
CIBC Private Wealth Group
Georgia
-$1.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
101
Financial Perspectives
Minnesota
$14.3K – – –
CAPTRUST Financial Advisors
102
CAPTRUST Financial Advisors
North Carolina
$13K – – –
HWM
103
HighMark Wealth Management
Minnesota
$13K +$13K +80 New
National Bank of Canada
104
National Bank of Canada
Quebec, Canada
$12K – – –
FFA
105
Freedman Financial Associates
Massachusetts
$12K +$11.3K +70 New
AA
106
Ancora Advisors
Ohio
$8K – – –
Citigroup
107
Citigroup
New York
$8K – – –
SWM
108
Spire Wealth Management
Virginia
$8K +$162 +1 +2%
GFPC
109
Global Financial Private Client
Florida
$7.3K – – –
PP
110
Pacifica Partners
Canada
$4K – – –
AIP
111
Ameritas Investment Partners
Nebraska
$3K – – –
VanEck Associates
112
VanEck Associates
New York
$3K – – –
VRM
113
Vectors Research Management
New York
$3K – – –
CFGS
114
Concourse Financial Group Securities
Alabama
$3K +$3.4K +21 New
BHWM
115
Beaird Harris Wealth Management
Texas
$1K – – –
Chevy Chase Trust
116
Chevy Chase Trust
Maryland
– -$2.61M -13,769 Closed
CIBC Private Wealth Group
117
CIBC Private Wealth Group
Georgia
– -$1.23M -6,473 Closed
Bank of New York Mellon
118
Bank of New York Mellon
New York
– -$602K -3,181 Closed
BPA
119
Beacon Pointe Advisors
California
– -$511K -2,700 Closed
CCM
120
Canal Capital Management
Virginia
– -$368K -1,945 Closed
FANJ
121
Financial Architects (New Jersey)
New Jersey
– -$241K -1,274 Closed
WS
122
Wedbush Securities
California
– -$237K -1,251 Closed
CDH
123
Charles D. Hyman
– -$227K -1,200 Closed
JWCA
124
J.W. Cole Advisors
Florida
– -$202K -1,068 Closed
Marshall Wace
125
Marshall Wace
United Kingdom
– -$194K -1,029 Closed
2 3 4
5
6

BBH Hedge Fund Activity: Q1 2022 in Review

115 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q1 2022, worth a combined $147M — down 14% from $171M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of BBH and 13 opened new positions — a net loss of 8 holders — while 35 trimmed existing stakes and 23 added.

The largest buyer was Traphagen Investment Advisors, adding an estimated $8.97M. The largest seller was Bank of America, cutting an estimated $9.88M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q1 2022, down from 126 in Q4 2021.
  • Funds reported $147M of VanEck Biotech ETF stock for Q1 2022, down 14% quarter-over-quarter.
  • 13 funds opened new VanEck Biotech ETF positions in Q1 2022 and 21 closed out, a net change of -8 holders.
  • The largest VanEck Biotech ETF buyer in Q1 2022 was Traphagen Investment Advisors, an estimated $8.97M added.
  • The largest VanEck Biotech ETF seller in Q1 2022 was Bank of America, an estimated $9.88M sold.

Based on aggregated 13F filings for Q1 2022.